Patient Pathfinder: Clinical Trials
Clinical Trials for Lung Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 986 active Lung Cancer trials
Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects
Study Type: Observational
A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer
Study Type: Interventional Phase 3
Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer
Study Type: Interventional Phase 1
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
Study Type: Interventional Phase 2
Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners
Study Type: Interventional
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
Study Type: Interventional Phase 1
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Study Type: Interventional Phase 3
4D-MRI for Precision Medicine
Study Type: Observational
There are 986 active Lung Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now